Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

SPARK Project to Examine DNA of 50,000 Autistic Kids, Looking for Solutions

April 26, 2016 10:13 am | by Seth Augenstein, Digital Reporter | News | Comments

A genomics research project hopes to collect and cross-reference the DNA of 50,000 people to better understand the autism spectrum.


New R&D Pact Seeks Cure for Aging-Related Diseases

April 26, 2016 10:06 am | by Ryan Bushey, Digital Editor | Articles | Comments

Google’s Calico, an institution with a mysterious mission to “cure death” could have competition from a new collaboration between Ascentage Pharma and Unity Biotechnology.


Study Proves Anti-Smoking Pills Don't Raise Suicide Risk

April 26, 2016 10:06 am | by Ryan Bushey, Digital Editor | Articles | Comments

Over the course of 12 weeks, patients were administered either Chantix or Zyban, a nicotine patch, or a placebo followed by an additional 12 weeks of follow-up.


Solving Structures of GLP-1, Glucagon Receptors for Metabolic Disease

April 26, 2016 9:40 am | News | Comments

Both receptors play important roles in the management of blood glucose levels and are considered to be important targets for drugs to treat metabolic diseases, such as diabetes.


HIV PrEP Too Pricey to Use in People Who Inject Drugs

April 26, 2016 9:32 am | by American College of Physicians | News | Comments

Even at lower drug prices, HIV PrEP for injection drug users may not be an efficient use of HIV prevention resources. 


Widely-Used Class of Chemo Drugs May Not Lead to Cognitive Decline

April 26, 2016 9:15 am | by UCLA | News | Comments

UCLA researchers have found that a commonly used chemotherapy drug does not appear to cause cognitive decline following treatment in women with breast cancer.


Fighting Against Counterfeit Medicine

April 26, 2016 8:37 am | by Michigan State University | News | Comments

Around the world, especially in developing nations, counterfeit medicines are a real problem.


Nutrient Supplements Can Give Antidepressants a Boost

April 26, 2016 8:35 am | by University of Melbourne | News | Comments

An international evidence review has found that certain nutritional supplements can increase the effectiveness of antidepressants for people with clinical depression.


FDA Approves AstraZeneca's Inhalation Treatment for COPD

April 26, 2016 8:31 am | News | Comments

Bevespi Aerosphere is the first product approved using AstraZeneca’s Co-Suspension Technology.


Compound Identified That Reverses Alzheimer's, Parkinson's Symptoms

April 26, 2016 8:25 am | by University of Maryland School of Medicine | News | Comments

Study in flies could have major implications for human disease.


Muscular Dystrophy Drug Falls Short at High-Stakes Meeting

April 26, 2016 8:20 am | by Matthew Perrone, AP Health Writer | News | Comments

While not binding, the panel's view carries weight in FDA's final decision whether to approve a drug.


Immune System Mystery Solved for Type 1 Diabetes

April 25, 2016 3:00 pm | by University of Lincoln | News | Comments

Scientists have solved a decades-old medical mystery by finally identifying a previously unknown molecule which is attacked by the immune system in people with Type 1 diabetes.


New Test Developed for Early Lyme Disease Detection

April 25, 2016 2:15 pm | by Medical University of Vienna | News | Comments

The current test is only able to analyze part of the human immune system, namely the B-cells but not the T-cells.


Soy Shows Promise as Natural Anti-Microbial Agent

April 25, 2016 1:42 pm | by University of Guelph | News | Comments

Soy isoflavones and peptides may inhibit the growth of microbial pathogens that cause food-borne illnesses. 


Valeant Names New CEO

April 25, 2016 12:20 pm | by Stephanie Guzowski, Editor | News | Comments

Canadian pharmaceutical company Valeant named Joseph Papa as its new chief executive and chairman on Monday.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.